Most Common Adverse Events of Checkpoint Inhibitors | Current Recommendations and Management
By: Meri Tarockoff, MD
Most Common Adverse Events of Checkpoint Inhibitors | Current Recommendations and Management
By: Meri Tarockoff, MD
Toxicity Profiles, Supportive Care and Challenges in Cancer Therapy Session
By: Nicole Ianniello, PharmD, Alga S. Ramos Morales, PharmD, MS, BCPS, BCOP, Ashwin Mehta, MD, MPH, Jorge J. Garcia, PharmD, MS, MHA, MBA, FACHE, Jorge Adames, PA, RN, BSN, OCN®, CCRP
Proton Therapy and Novel Energy Approaches in Cancer Care
By: Timothy R. Williams, MD, FACRO, FASTRO
Proton Therapy and Novel Energy Approaches in Cancer Care
By: Timothy R. Williams, MD, FACRO, FASTRO
CAR-T Cells and BMT Learning How to Deal with Complications
By: Adalberto Torres-Hernandez, MSN, BA, CERN, CWCMS
Integrative Oncology: Treatment Approaches for Stress in Cancer Patients and Survivors
By: Ashwin Mehta, MD, MPH
The Role of Liquid Biopsy in Cancer Care: The Revolution
By: Christian Rolfo - MD - PhD - MBA - Dr.h.c.
Management of ImmuneRelated Adverse Events “the guard dog that attacks the owner”
By: Christine Teklehaimanote, MSN, GNP-BC, AOCNP
